Yiran Tao

1.1k total citations
55 papers, 680 citations indexed

About

Yiran Tao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yiran Tao has authored 55 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yiran Tao's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Prostate Cancer Treatment and Research (6 papers) and Ubiquitin and proteasome pathways (4 papers). Yiran Tao is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Prostate Cancer Treatment and Research (6 papers) and Ubiquitin and proteasome pathways (4 papers). Yiran Tao collaborates with scholars based in China, United States and Hong Kong. Yiran Tao's co-authors include Jinliang Yang, Yuxi Wang, Hai Huang, Yuk Ming Tang, Ka Yin Chau, Kaiwen Li, Yujia Peng, Ya Zhang, Jun Li and Liqiang Hu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Communications and Journal of Controlled Release.

In The Last Decade

Yiran Tao

51 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiran Tao China 16 289 142 132 98 87 55 680
Liqin Yuan China 15 279 1.0× 175 1.2× 162 1.2× 74 0.8× 81 0.9× 29 676
Qingjun You China 14 297 1.0× 76 0.5× 166 1.3× 89 0.9× 58 0.7× 44 615
Yogesh Rai India 10 249 0.9× 71 0.5× 114 0.9× 46 0.5× 37 0.4× 22 615
Apurva K. Srivastava United States 18 618 2.1× 188 1.3× 153 1.2× 99 1.0× 38 0.4× 50 1.0k
Zubaidah Zakaria Malaysia 22 577 2.0× 317 2.2× 223 1.7× 71 0.7× 70 0.8× 69 1.3k
Kuansong Wang China 14 320 1.1× 185 1.3× 132 1.0× 94 1.0× 87 1.0× 34 759
Ching Wan Chan Singapore 14 304 1.1× 178 1.3× 194 1.5× 68 0.7× 28 0.3× 31 711
Mike F. Burbridge France 19 567 2.0× 250 1.8× 178 1.3× 112 1.1× 145 1.7× 33 970
Yuting Chen China 22 497 1.7× 220 1.5× 191 1.4× 129 1.3× 102 1.2× 68 1.1k
Huiwei Sun China 16 388 1.3× 249 1.8× 280 2.1× 80 0.8× 74 0.9× 24 783

Countries citing papers authored by Yiran Tao

Since Specialization
Citations

This map shows the geographic impact of Yiran Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiran Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiran Tao more than expected).

Fields of papers citing papers by Yiran Tao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiran Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiran Tao. The network helps show where Yiran Tao may publish in the future.

Co-authorship network of co-authors of Yiran Tao

This figure shows the co-authorship network connecting the top 25 collaborators of Yiran Tao. A scholar is included among the top collaborators of Yiran Tao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiran Tao. Yiran Tao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tao, Yiran, et al.. (2025). Matrix stiffness maintains bladder cancer stemness via integrin-nuclear skeleton axis. Cell Death and Disease. 16(1). 887–887.
2.
3.
Tao, Yiran, et al.. (2025). Molecular glue meets antibody: next-generation antibody–drug conjugates. Trends in Pharmacological Sciences. 46(6). 520–534. 4 indexed citations
4.
Yu, Hao, Jiancheng Lv, Lingjing Jiang, et al.. (2025). SRSF1-mediated alternative splicing regulates bladder cancer progression and cisplatin sensitivity through HIF1A/BNIP3/mitophagy axis. Journal of Translational Medicine. 23(1). 571–571. 1 indexed citations
5.
6.
Li, Zhang, et al.. (2024). X-SEM: A modeling and simulation-based system engineering methodology. Journal of Manufacturing Systems. 74. 198–221. 3 indexed citations
7.
8.
Wang, Qiong, Bisheng Cheng, Sandeep Singh, et al.. (2024). A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3. npj Precision Oncology. 8(1). 11–11. 21 indexed citations
9.
Tao, Yiran, Yu Zhang, Yumeng Li, et al.. (2024). Computer-aided designing of a novel multi‑epitope DNA vaccine against severe fever with thrombocytopenia syndrome virus. BMC Infectious Diseases. 24(1). 476–476. 3 indexed citations
10.
Wang, Rui, Yiran Tao, Liqiang Hu, et al.. (2023). Temporal Proteomic and Lipidomic Profiles of Cerulein-Induced Acute Pancreatitis Reveal Novel Insights for Metabolic Alterations in the Disease Pathogenesis. ACS Omega. 8(13). 12310–12326. 5 indexed citations
11.
Yao, Jiaqi, Yiran Tao, Zelin Hu, et al.. (2023). Optimization of small molecule degraders and antagonists for targeting estrogen receptor based on breast cancer: current status and future. Frontiers in Pharmacology. 14. 1225951–1225951. 4 indexed citations
12.
Tao, Yiran, Chunlei Dai, Xinru You, et al.. (2023). Redox responsive polymeric nanoparticles enhance the efficacy of cyclin dependent kinase 7 inhibitor for enhanced treatment of prostate cancer. Chinese Chemical Letters. 35(8). 109170–109170. 8 indexed citations
13.
Li, Zean, et al.. (2023). SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion. Journal of Translational Medicine. 21(1). 303–303. 6 indexed citations
14.
Xu, Chengdang, Xinan Wang, Yiran Tao, et al.. (2023). Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression. Cell Death Discovery. 9(1). 392–392. 4 indexed citations
15.
Hu, Liqiang, Yiran Tao, Yanjiao Jiang, & Feng Qin. (2023). Recent progress of nanomedicine in the treatment of Alzheimer’s disease. Frontiers in Cell and Developmental Biology. 11. 1228679–1228679. 25 indexed citations
16.
Hong, Tao, et al.. (2022). TPRG1 contributes to inflammation and cell proliferation of cystitis glandularis through regulating NF-кB/COX2/PGE2 axis. Bosnian Journal of Basic Medical Sciences. 22(1). 100–109. 2 indexed citations
17.
18.
Li, Zean, Qiong Wang, Kai Yao, et al.. (2020). The metastatic promoter DEPDC1B induces epithelial‐mesenchymal transition and promotes prostate cancer cell proliferation via Rac1‐PAK1 signaling. SHILAP Revista de lepidopterología. 10(6). e191–e191. 45 indexed citations
19.
Gao, Ze, Yiran Tao, Yiming Lai, et al.. (2020). Immune Cytolytic Activity as an Indicator of Immune Checkpoint Inhibitors Treatment for Prostate Cancer. Frontiers in Bioengineering and Biotechnology. 8. 930–930. 21 indexed citations
20.
Li, Xiaojuan, Jun Li, Yi Cai, et al.. (2018). Hyperglycaemia-induced miR-301a promotes cell proliferation by repressing p21 and Smad4 in prostate cancer. Cancer Letters. 418. 211–220. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liqin Yuan Breakdown of academic impact, for papers by Qingjun You Breakdown of academic impact, for papers by Yogesh Rai Breakdown of academic impact, for papers by Apurva K. Srivastava Breakdown of academic impact, for papers by Zubaidah Zakaria Breakdown of academic impact, for papers by Kuansong Wang Breakdown of academic impact, for papers by Ching Wan Chan Breakdown of academic impact, for papers by Mike F. Burbridge Breakdown of academic impact, for papers by Yuting Chen Breakdown of academic impact, for papers by Huiwei Sun
Rankless by CCL
2026